… plus a platinum and 5-fluorouracil (pembrolizumab with … superiority of pembrolizumab alone
and of pembrolizumab with … margin: 1·2) of pembrolizumab alone and pembrolizumab with …

… KEYNOTE-048 investigated pembrolizumab monotherapy and pembrolizumab plus
chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. Efficacy was …

… had pathologically confirmed squamous cell carcinoma of the … pembrolizumab alone (pembrolizumab
200 mg every 3 weeks [Q3W]), pembrolizumab-chemotherapy (pembrolizumab …

… to pembrolizumab plus … ), pembrolizumab plus chemotherapy was superior to placebo plus
chemotherapy for overall survival in patients with oesophageal squamous cell carcinoma and …

… non-small cell lung … pembrolizumab alone and in combination for melanoma, NSCLC, and
other tumor types. In this article, we review the efficacy and toxicity profile of pembrolizumab …

… observed with pembrolizumab alone and pembrolizumab-… Retreatment with pembrolizumab
provided benefit in some … of pembrolizumab alone versus cetuximab-chemotherapy and …

… The safety profile of pembrolizumab monotherapy in the … of pembrolizumab in other tumor
types. Commonly reported grade 3/4 treatment-related AEs associated with pembrolizumab …

… trials that compared pembrolizumab plus chemotherapy or pembrolizumab alone with … ,
with the search terms including pembrolizumab, non–small cell lung cancer, and randomized …

… Clinical data from a phase 2 study investigating the combination of the BTK inhibitor
acalabrutinib and PD-1 inhibitor pembrolizumab compared with pembrolizumab alone were …

… plus chemotherapy has shown a high level of activity as compared with chemotherapy alone…
whether pembrolizumab plus chemotherapy has greater efficacy than pembrolizumab alone…